Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Financing Activities (2016 - 2026)

Organogenesis Holdings has reported Cash from Financing Activities over the past 10 years, most recently at -$4.8 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 114.29% year-over-year to -$4.8 million; the TTM value through Dec 2025 reached -$17.4 million, down 162.81%, while the annual FY2025 figure was -$17.4 million, 162.81% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$4.8 million at Organogenesis Holdings, up from -$10.2 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $33.6 million in Q4 2024 and troughed at -$10.2 million in Q3 2025.
  • A 5-year average of $76850.0 and a median of -$1.1 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 5630.77% in 2023 and later skyrocketed 1993.58% in 2024.
  • Year by year, Cash from Financing Activities stood at -$917000.0 in 2021, then tumbled by 104.47% to -$1.9 million in 2022, then rose by 5.23% to -$1.8 million in 2023, then skyrocketed by 1993.58% to $33.6 million in 2024, then plummeted by 114.29% to -$4.8 million in 2025.
  • Business Quant data shows Cash from Financing Activities for ORGO at -$4.8 million in Q4 2025, -$10.2 million in Q3 2025, and -$288000.0 in Q2 2025.